| abstract |
The present invention relates to HSP70 and T cell epitopes, B cell epitopes of foot and mouth disease virus O serotype and A serotype, delivery material or carrier molecule, VP1 site of foot and mouth disease virus, active site gene of immune-enhancing peptide, and Invasin gene, which is a universal T cell epitope. It relates to a foot-and-mouth disease recombinant virus that has been inserted into a new recombinant protein that has a strong defense effect against foot-and-mouth disease virus infection by inducing cellular and humoral immune responses at the same time, thereby enhancing early, mid-term and long-term immune responses. It relates to a vaccine composition for. |